← Back to the home page
GLP-1 / Weight Management

Cagrilintide 5mg

Lab-made version of amylin, a hormone released alongside insulin.

10mg5mg
Sold as
Box of 10 vials, 5mg each
Form
Freeze-dried (lyophilised) powder in a sealed, plain unlabelled vial

Apply for a trade account

Cagrilintide 5mg vial, research use only

About Cagrilintide

What it is

Cagrilintide is a man-made, long-acting version of amylin. Amylin is a hormone the pancreas releases together with insulin after a meal.

How it works

It binds to amylin receptors and also to calcitonin receptors. In the body, these receptors are part of the signals linked to fullness and to how fast the stomach empties.

What it has been studied for

  • appetite and weight regulation
  • blood sugar control in type 2 diabetes
  • combination with semaglutide (CagriSema)

Status

Not an approved medicine in South Africa. Novo Nordisk has tested it in phase 3 trials, mostly combined with semaglutide as 'CagriSema', and asked the US FDA to approve CagriSema in December 2025. We could not confirm whether that review is finished, so please check the latest status yourself. This product is not a medicine.

Storage

Keep the vial sealed in a fridge (2-8 °C), away from light and moisture. For longer storage, many people keep it in a freezer (-20 °C). Do not leave it in heat or direct sun.

For research use only. Not a medicine, not for human or veterinary use. This page explains the compound for researchers and trade buyers; it is not medical advice.